If you’ve been comparing options for treating stubborn melasma, you’ve likely run into three names that sound almost interchangeable: Melalite XL, Melamet Cream, and Triluma Cream. All three are triple-combination creams. All three combine a lightening agent, a retinoid, and a corticosteroid. And all three are used to treat the same core problem — moderate-to-severe melasma and stubborn hyperpigmentation. But there are real differences between them, in strength, formulation, regulatory status, and cost, that make this comparison worth understanding before you and your dermatologist settle on one.
The Quick Answer
Melalite XL and Melamet Cream are near-identical formulations: both combine Hydroquinone 2%, Tretinoin 0.025%, and Mometasone Furoate 0.1%. They’re essentially generic equivalents of each other, sold under different brand names, typically at similar price points.
Triluma Cream is a different, stronger formulation — Hydroquinone 4%, Tretinoin 0.05%, and Fluocinolone Acetonide 0.01% — and it holds a distinction the other two don’t: it’s the only FDA-approved topical treatment specifically indicated for moderate-to-severe facial melasma, backed by dedicated clinical trial data.
In short: Melalite XL and Melamet are two versions of essentially the same moderate-strength combination therapy, while Triluma is a higher-concentration, clinically validated alternative with a more defined treatment protocol.
What Is Melalite XL?
Melalite XL is a triple-combination cream containing Hydroquinone 2%, Tretinoin 0.025%, and Mometasone Furoate 0.1%. It’s often described as a modified version of the classic “Kligman formula” approach to melasma treatment, combining a melanin-production inhibitor, a cell-turnover accelerator, and an anti-inflammatory steroid in one product. It’s typically prescribed for moderate-to-severe melasma that hasn’t responded sufficiently to single-ingredient hydroquinone treatments, and it’s meant for short, defined treatment courses rather than continuous long-term use, given the steroid component.
What Is Melamet Cream?
Melamet Cream, manufactured by Cadila, contains the exact same three active ingredients at the exact same concentrations as Melalite XL: Hydroquinone 2%, Tretinoin 0.025%, and Mometasone Furoate 0.1%. It’s marketed as a generic alternative to the branded product Skin Lite, and functionally, it works identically to Melalite XL — same mechanisms, same expected results, same precautions around duration of use.
The practical difference between choosing Melalite XL or Melamet Cream typically comes down to manufacturer, pharmacy availability, price, and minor differences in inactive ingredients or cream base — not clinical effectiveness, since the active ingredient profile is identical.
What Is Triluma Cream?
Triluma Cream, manufactured by Galderma, is a different formulation altogether: Hydroquinone 4%, Tretinoin 0.05%, and Fluocinolone Acetonide 0.01%. Every active ingredient is present at a higher concentration than in Melalite XL or Melamet, and it uses a different corticosteroid — fluocinolone acetonide rather than mometasone furoate.
What sets Triluma apart most isn’t just its strength, though — it’s regulatory status. Triluma is the only topical treatment in this category that has gone through FDA approval specifically for moderate-to-severe facial melasma, with clinical trials showing that a substantial majority of patients experienced complete or near-complete clearing of melasma within an 8-week treatment course. Its prescribing information explicitly limits use to that short-term window and states it isn’t intended for ongoing maintenance treatment.
Comparing the Three Formulations
| Melalite XL | Melamet Cream | Triluma Cream | |
|---|---|---|---|
| Hydroquinone | 2% | 2% | 4% |
| Tretinoin | 0.025% | 0.025% | 0.05% |
| Corticosteroid | Mometasone Furoate 0.1% | Mometasone Furoate 0.1% | Fluocinolone Acetonide 0.01% |
| FDA-approved for melasma | No (used off-label based on established mechanism) | No (used off-label based on established mechanism) | Yes — the only FDA-approved treatment for this specific use |
| Typical treatment duration | Short-term, weeks (steroid-limited) | Short-term, weeks (steroid-limited) | Up to 8 weeks per labeling; not for maintenance |
| Relative strength | Moderate | Moderate | Higher concentration across all three ingredients |
| Cost | Generally lower (generic) | Generally lower (generic) | Generally higher (brand-associated combination) |
How the Formulations Differ in Practice
Since Melalite XL and Melamet share identical active ingredients, there’s genuinely no meaningful difference in how they perform — choosing between them is more a matter of what your pharmacy stocks or which is priced better that week than a clinical decision.
Triluma’s differences are more substantive. Its higher hydroquinone concentration (4% vs. 2%) means more melanin-production inhibition per application. Its higher tretinoin concentration (0.05% vs. 0.025%) means more aggressive cell turnover. And its corticosteroid, fluocinolone acetonide, is generally considered a milder-potency steroid compared to mometasone furoate, which is one reason some dermatologists view Triluma’s anti-inflammatory component as slightly gentler even while its active-ingredient concentrations elsewhere are higher. The net effect is a formulation built for a more intensive, clinically studied short course, rather than the moderate, flexible approach that Melalite XL and Melamet are typically used for.
Effectiveness: What the Evidence Shows
This is where Triluma’s distinction as an FDA-approved product matters most. Its approval was backed by clinical trials specifically measuring melasma clearance, with a large majority of patients showing complete or near-complete improvement by the 8-week mark. That’s a specific, published, melasma-focused evidence base.
Melalite XL and Melamet, by contrast, are used for melasma based on the well-established, decades-long track record of their individual ingredients — hydroquinone, tretinoin, and topical corticosteroids each have strong independent evidence for treating hyperpigmentation and inflammation, and combining them follows a logic that’s been used in dermatology for a long time. But neither product has gone through melasma-specific FDA trials of its own. In practice, many dermatologists find them effective, particularly for moderate cases, but the clinical evidence supporting Triluma for this exact indication is more direct.
Duration of Use: A Shared Constraint
All three of these creams contain a corticosteroid, which means all three come with the same core limitation: they’re not meant for continuous, indefinite use. Extended use of a steroid-containing combination cream increases the risk of skin thinning, stretch marks, visible blood vessels, and rebound pigmentation or redness once treatment stops.
Triluma’s limit is the most clearly defined — up to 8 weeks per its FDA labeling, with explicit guidance that it isn’t intended for maintenance therapy afterward. Melalite XL and Melamet don’t carry the same formally studied duration limit, but the same underlying steroid-related risks apply, and most dermatologists prescribe them for similarly short, defined courses rather than continuous use.
Side Effects Across the Three
Side effects are broadly similar across all three products, given their shared ingredient categories, though there are some distinctions worth knowing.
Common to all three: redness, stinging, burning, dryness, peeling, and increased sun sensitivity, particularly during the first couple of weeks of treatment.
More specific to Melalite XL and Melamet: because mometasone furoate is generally a stronger-potency steroid than fluocinolone acetonide, some patients may notice steroid-related effects, like localized thinning with extended use, developing somewhat sooner if treatment duration isn’t carefully managed.
More specific to Triluma: its formulation contains sodium metabisulfite as an inactive ingredient, which can trigger allergic reactions, including asthma-like symptoms, in sulfite-sensitive individuals. Its higher tretinoin concentration also carries a specific pregnancy warning, since tretinoin is a known teratogen — Triluma’s prescribing information states it should only be used during pregnancy if the potential benefit outweighs the risk, as determined by a doctor.
Who Should Consider Each Option?
Melalite XL or Melamet Cream may be a reasonable starting point for:
- Moderate melasma or hyperpigmentation that hasn’t responded to hydroquinone alone
- Patients looking for a more affordable, generic combination therapy
- Situations where either brand is more readily available through your pharmacy
Triluma Cream may be worth prioritizing for:
- Moderate-to-severe facial melasma specifically, especially treatment-resistant cases
- Patients who want a treatment backed by dedicated FDA clinical trial data
- A clearly defined, time-limited treatment course with an established evidence base for what to expect by week 8
- Patients without sulfite sensitivity or other contraindications specific to its formulation
Cost and Practical Considerations
Because Melalite XL and Melamet are generic, moderate-strength combination products, they’re typically priced lower than Triluma, which carries brand-name development and manufacturing costs alongside its higher-concentration formulation. For patients trying combination therapy for the first time, or those managing a more moderate case of melasma, starting with the lower-cost generic option and stepping up to Triluma if results are insufficient is a reasonably common and cost-conscious approach — though this decision should be guided by your dermatologist’s assessment of severity, not price alone.
Can You Switch Between Them?
Yes, and it’s common in practice. If Melalite XL or Melamet Cream doesn’t produce sufficient improvement after a reasonable treatment course, a dermatologist might step up to Triluma’s higher concentrations and clinically validated protocol for a more intensive course. Conversely, after completing a course of Triluma, many patients transition to a gentler maintenance treatment — sometimes a single-agent hydroquinone product, sometimes a lower-strength combination like Melalite XL or Melamet, used cautiously and for a limited duration — to help sustain results without prolonged steroid exposure.
Because Melalite XL and Melamet are functionally identical, switching between those two specifically is really just a practical or cost-based decision rather than a clinical one — there’s no meaningful reason to prefer one over the other beyond availability and price.
A Few Questions Worth Asking Before You Start
Whichever of the three you and your dermatologist are considering, a short list of questions can help clarify which one actually fits your situation, rather than choosing based on price or brand recognition alone. Ask how your melasma would be classified in terms of severity, since that distinction often determines whether a moderate-strength option like Melalite XL or Melamet is sufficient, or whether Triluma’s higher concentrations are more appropriate. Ask whether you have any history of steroid sensitivity, sulfite allergy, eczema, or rosacea, since these matter differently across the three formulations given their different corticosteroids and inactive ingredients.
If you’re pregnant, planning to become pregnant, or breastfeeding, raise this directly and specifically — Triluma’s higher tretinoin concentration carries a more pronounced pregnancy warning than the lower-dose tretinoin in Melalite XL or Melamet, though all three warrant caution. Finally, ask what your plan looks like after the initial treatment course ends, since all three creams share the same core limitation: none of them are meant for indefinite use, and having a maintenance strategy in place from the start helps avoid the temptation to keep using a steroid-containing formula longer than intended simply because results have been encouraging.
A patch test before starting any of the three is also worth doing regardless of which one you choose — apply a small amount to an inconspicuous area near the affected skin and wait 24 hours to check for irritation or an allergic reaction before beginning full treatment.
Which One Should You Choose?
If cost and general effectiveness for moderate melasma are your priority, Melalite XL and Melamet Cream offer a well-established, more affordable combination therapy — and there’s no real reason to choose one over the other beyond what your pharmacy has available. If you’re dealing with more severe, treatment-resistant melasma and want the option with the strongest clinical evidence base and FDA approval specifically for this condition, Triluma Cream is the more rigorously studied choice, with the understanding that it’s a short, defined course rather than an ongoing treatment.
As with any triple-combination therapy, the right choice depends on the severity of your melasma, your skin’s history with previous treatments, and any specific sensitivities like sulfite allergy that might steer you toward one formulation over another. That’s a conversation worth having directly with a dermatologist, who can weigh your specific case against what each of these three options is actually built to do.
This article is for general informational purposes and does not replace advice from a licensed dermatologist or healthcare provider. Product selection, treatment duration, and any transition between formulations should always be determined with a doctor.